| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.5K | Jun 14, 2023 | Direct | ||
| Black Diamond Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16.5K | May 16, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| BDTX | Black Diamond Therapeutics, Inc. | May 16, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| BDTX | Black Diamond Therapeutics, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | Director |
| BDTX | Black Diamond Therapeutics, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |